• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度新冠大流行死亡人数的另一种估计。

An alternative estimation of the death toll of the Covid-19 pandemic in India.

机构信息

Centre des Sciences Humaines, Delhi, India.

Ceped/IRD/Université de Paris/INSERM, Paris, France.

出版信息

PLoS One. 2022 Feb 16;17(2):e0263187. doi: 10.1371/journal.pone.0263187. eCollection 2022.

DOI:10.1371/journal.pone.0263187
PMID:35171925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8849468/
Abstract

The absence of reliable registration of Covid-19 deaths in India has prevented proper assessment and monitoring of the coronavirus pandemic. In addition, India's relatively young age structure tends to conceal the severity of Covid-19 mortality, which is concentrated in older age groups. In this paper, we present four different demographic samples of Indian populations for which we have information on both their demographic structures and death outcomes. We show that we can model the age distribution of Covid-19 mortality in India and use this modeling to estimate Covid-19 mortality in the country. Our findings point to a death toll of approximately 3.2-3.7 million persons by early November 2021. Once India's age structure is factored in, these figures correspond to one of the most severe cases of Covid-19 mortality in the world. India has recorded after February 2021 the second outbreak of coronavirus that has affected the entire country. The accuracy of official statistics of Covid-19 mortality has been questioned, and the real number of Covid-19 deaths is thought to be several times higher than reported. In this paper, we assembled four independent population samples to model and estimate the level of Covid-19 mortality in India. We first used a population sample with the age and sex of Covid-19 victims to develop a Gompertz model of Covid-19 mortality in India. We applied and adjusted this mortality model on two other national population samples after factoring in the demographic characteristics of these samples. We finally derive from these samples the most reasonable estimate of Covid-19 mortality level in India and confirm this result using a fourth population sample. Our findings point to a death toll of about 3.2-3.7 million persons by late May 2021. This is by far the largest number of Covid-19 deaths in the world. Once standardized for age and sex structure, India's Covid-19 mortality rate is above Brazil and the USA. Our analysis shows that existing population samples allow an alternative estimation of deaths due to Covid-19 in India. The results imply that only one out of 7-8 deaths appear to have been recorded as a Covid-19 death in India. The estimates also point to a very high Covid-19 mortality rate, which is even higher after age and sex standardization. The magnitude of the pandemic in India requires immediate attention. In the absence of effective remedies, this calls for a strong response based on a combination of non-pharmaceutical interventions and the scale-up of vaccination to make them accessible to all, with an improved surveillance system to monitor the progression of the pandemic and its spread across India's regions and social groups.

摘要

印度缺乏可靠的新冠死亡登记,这使得对冠状病毒大流行的适当评估和监测受到阻碍。此外,印度相对年轻的年龄结构往往掩盖了新冠死亡率的严重程度,新冠死亡率主要集中在年龄较大的群体中。在本文中,我们提出了印度人口的四个不同的人口学样本,我们掌握了这些样本的人口结构和死亡结果信息。我们表明,我们可以对印度新冠死亡率的年龄分布进行建模,并使用该模型来估计印度的新冠死亡率。我们的研究结果表明,到 2021 年 11 月初,印度的死亡人数约为 320 万至 370 万。考虑到印度的年龄结构后,这些数字相当于世界上最严重的新冠死亡病例之一。自 2021 年 2 月以来,印度记录了第二次冠状病毒爆发,该爆发影响了全国。新冠死亡率的官方统计数据的准确性受到了质疑,实际的新冠死亡人数被认为比报告的高出数倍。在本文中,我们收集了四个独立的人口样本,以对印度的新冠死亡率进行建模和估计。我们首先使用一个包含新冠病毒受害者年龄和性别的人口样本,建立了一个印度新冠死亡率的戈曼模型。在考虑了这些样本的人口特征后,我们将这个死亡率模型应用于另外两个全国性人口样本,并对其进行了调整。最后,我们从这些样本中得出了印度新冠死亡率水平的最合理估计,并使用第四个人口样本对该结果进行了验证。我们的研究结果表明,到 2021 年 5 月底,印度的死亡人数约为 320 万至 370 万。这是迄今为止世界上新冠死亡人数最多的国家。在按年龄和性别结构标准化后,印度的新冠死亡率高于巴西和美国。我们的分析表明,现有的人口样本可以对印度因新冠病毒死亡的人数进行替代估计。研究结果表明,印度只有 1/7-1/8 的新冠死亡病例被记录为新冠死亡病例。这些估计还表明,新冠死亡率非常高,在按年龄和性别标准化后更高。印度大流行的规模需要立即引起关注。在缺乏有效补救措施的情况下,这需要采取一种强有力的应对措施,这种措施基于非药物干预措施和扩大疫苗接种的结合,使所有人都能获得疫苗,并建立一个改进的监测系统,以监测大流行的进展及其在印度各地区和社会群体中的传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc0/8849468/2c2af68f5248/pone.0263187.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc0/8849468/e29a2fc72e92/pone.0263187.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc0/8849468/2c2af68f5248/pone.0263187.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc0/8849468/e29a2fc72e92/pone.0263187.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc0/8849468/2c2af68f5248/pone.0263187.g002.jpg

相似文献

1
An alternative estimation of the death toll of the Covid-19 pandemic in India.印度新冠大流行死亡人数的另一种估计。
PLoS One. 2022 Feb 16;17(2):e0263187. doi: 10.1371/journal.pone.0263187. eCollection 2022.
2
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球 204 个国家和地区及 811 个亚级行政区 1990 年至 2021 年 288 种死因及预期寿命的归因分析:全球疾病负担研究 2021 系统分析。
Lancet. 2024 May 18;403(10440):2100-2132. doi: 10.1016/S0140-6736(24)00367-2. Epub 2024 Apr 3.
3
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.204 个国家和地区及 811 个次国家级行政单位 1950 年至 2021 年的全球年龄、性别特异性死亡率、预期寿命和人口估计,以及 COVID-19 大流行的影响:2021 年全球疾病负担研究的综合人口分析。
Lancet. 2024 May 18;403(10440):1989-2056. doi: 10.1016/S0140-6736(24)00476-8. Epub 2024 Mar 11.
4
Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.估算2019冠状病毒病大流行造成的超额死亡率:2020 - 2021年与2019冠状病毒病相关死亡率的系统分析
Lancet. 2022 Apr 16;399(10334):1513-1536. doi: 10.1016/S0140-6736(21)02796-3. Epub 2022 Mar 10.
5
All-cause mortality during the COVID-19 pandemic in Chennai, India: an observational study.印度钦奈市 COVID-19 大流行期间的全因死亡率:一项观察性研究。
Lancet Infect Dis. 2022 Apr;22(4):463-472. doi: 10.1016/S1473-3099(21)00746-5. Epub 2021 Dec 22.
6
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
7
Age-specific and sex-specific adult mortality risk in India in 2014: analysis of 0·27 million nationally surveyed deaths and demographic estimates from 597 districts.2014 年印度按年龄和性别划分的成人死亡率:0·27 万例全国死因调查和 597 个区人口估计数据的分析。
Lancet Glob Health. 2015 Dec;3(12):e767-75. doi: 10.1016/S2214-109X(15)00091-1.
8
COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data.俄罗斯圣彼得堡的 COVID-19 疫情:结合基于人群的血清学研究和监测数据。
PLoS One. 2022 Jun 15;17(6):e0266945. doi: 10.1371/journal.pone.0266945. eCollection 2022.
9
Subnational mortality estimates for India in 2019: a baseline for evaluating excess deaths due to the COVID-19 pandemic.2019 年印度的国家级死亡率估计:评估 COVID-19 大流行导致超额死亡的基线。
BMJ Glob Health. 2021 Nov;6(11). doi: 10.1136/bmjgh-2021-007399.
10
COVID-19 vaccination strategies and policies in India: The need for further re-evaluation is a pressing priority.印度的新冠疫苗接种策略与政策:进一步重新评估的必要性是当务之急。
Int J Health Plann Manage. 2022 May;37(3):1847-1850. doi: 10.1002/hpm.3321. Epub 2021 Sep 12.

引用本文的文献

1
Efficacy of Ayurvedic treatment given to cancer patients in the prevention of COVID-19 - A Retrospective Cohort Study at Integrated Cancer Treatment and Research Centre, Wagholi.阿育吠陀疗法对癌症患者预防COVID-19的疗效——瓦戈利综合癌症治疗与研究中心的一项回顾性队列研究
J Ayurveda Integr Med. 2025 Mar 5;16(2):101045. doi: 10.1016/j.jaim.2024.101045.
2
Prevalence and predictors of suicide ideation among university and high-school students during India's 2nd wave of the COVID-19 pandemic.印度第二波新冠疫情期间大学生和高中生自杀意念的患病率及预测因素
PLoS One. 2024 Dec 5;19(12):e0311403. doi: 10.1371/journal.pone.0311403. eCollection 2024.
3

本文引用的文献

1
Estimates of pandemic excess mortality in India based on civil registration data.基于民事登记数据对印度大流行期间超额死亡率的估计。
PLOS Glob Public Health. 2022 Dec 9;2(12):e0000803. doi: 10.1371/journal.pgph.0000803. eCollection 2022.
2
All-cause excess mortality across 90 municipalities in Gujarat, India, during the COVID-19 pandemic (March 2020-April 2021).2020年3月至2021年4月新冠疫情期间,印度古吉拉特邦90个市政当局的全因超额死亡率。
PLOS Glob Public Health. 2022 Aug 16;2(8):e0000824. doi: 10.1371/journal.pgph.0000824. eCollection 2022.
3
Preliminary Analysis of Excess Mortality in India During the COVID-19 Pandemic.
Large and unequal life expectancy declines during the COVID-19 pandemic in India in 2020.
2020 年,印度在 COVID-19 大流行期间出现了巨大且不平等的预期寿命下降。
Sci Adv. 2024 Jul 19;10(29):eadk2070. doi: 10.1126/sciadv.adk2070.
4
Analysis of anthropometric outcomes in Indian children during the COVID-19 pandemic using National Family Health Survey data.利用全国家庭健康调查数据对新冠疫情期间印度儿童的人体测量结果进行分析。
Commun Med (Lond). 2024 Jul 1;4(1):127. doi: 10.1038/s43856-024-00543-6.
5
Evaluation of the exit screening policy among travelers arriving from Asian and pacific nations.评估来自亚洲和太平洋国家的旅行者的离境筛查政策。
BMC Infect Dis. 2024 May 2;24(1):464. doi: 10.1186/s12879-024-09327-8.
6
Influence of COVID-19 pandemic in India on coronary artery disease clinical presentation, angiography, interventions and in-hospital outcomes: a single centre prospective registry-based observational study.印度 COVID-19 大流行对冠心病临床表现、血管造影、介入治疗和住院结局的影响:一项基于单中心前瞻性登记的观察性研究。
BMJ Open. 2024 Mar 29;14(3):e078596. doi: 10.1136/bmjopen-2023-078596.
7
The COVID-19 pandemic death toll in India: can we know better?印度新冠疫情死亡人数:我们能更清楚地了解吗?
BMJ Glob Health. 2023 Aug;8(8). doi: 10.1136/bmjgh-2023-012818.
8
A systematic review of excess all-cause mortality estimation studies in India during COVID-19 pandemic.对印度在新冠疫情期间全因超额死亡率估计研究的系统评价。
Med J Armed Forces India. 2023 Apr 15;79(5):506-15. doi: 10.1016/j.mjafi.2023.02.008.
9
Global and National Declines in Life Expectancy: An End-of-2021 Assessment.全球及各国预期寿命下降:2021年末评估
Popul Dev Rev. 2022 Mar;48(1):31-50. doi: 10.1111/padr.12477. Epub 2022 Mar 12.
10
Impact of COVID-19 on utilization of maternal and child health services in India: Health management information system data analysis.2019年冠状病毒病对印度母婴健康服务利用情况的影响:卫生管理信息系统数据分析
Clin Epidemiol Glob Health. 2023 May-Jun;21:101285. doi: 10.1016/j.cegh.2023.101285. Epub 2023 Mar 31.
新冠疫情期间印度超额死亡率的初步分析
Am J Trop Med Hyg. 2022 Apr 4;106(5):1507-10. doi: 10.4269/ajtmh.21-0864.
4
Assessing mortality registration in Kerala: the MARANAM study.评估喀拉拉邦的死亡率登记情况:玛拉南姆研究
Genus. 2022;78(1):1. doi: 10.1186/s41118-021-00149-z. Epub 2022 Jan 10.
5
COVID mortality in India: National survey data and health facility deaths.印度的 COVID 死亡率:全国调查数据和卫生机构死亡人数。
Science. 2022 Feb 11;375(6581):667-671. doi: 10.1126/science.abm5154. Epub 2022 Jan 6.
6
The COVID-19-Social Identity-Digital Media Nexus in India: Polarization and Blame.印度的新冠疫情、社会身份与数字媒体关系:两极分化与指责
Polit Psychol. 2021 Oct;42(5):827-844. doi: 10.1111/pops.12774. Epub 2021 Jul 18.
7
Estimating COVID-19‒ Related Mortality in India: An Epidemiological Challenge With Insufficient Data.估算印度新冠肺炎相关死亡率:数据不足带来的流行病学挑战
Am J Public Health. 2021 Jul;111(S2):S59-S62. doi: 10.2105/AJPH.2021.306419.
8
India's COVID-19 emergency.印度的新冠疫情紧急情况。
Lancet. 2021 May 8;397(10286):1683. doi: 10.1016/S0140-6736(21)01052-7.
9
Stigma and misconceptions in the time of the COVID-19 pandemic: A field experiment in India.新冠疫情时期的污名与误解:印度实地实验。
Soc Sci Med. 2021 Jun;278:113966. doi: 10.1016/j.socscimed.2021.113966. Epub 2021 Apr 28.
10
Beyond deaths per capita: comparative COVID-19 mortality indicators.超越人均死亡数:比较 COVID-19 死亡率指标。
BMJ Open. 2021 Mar 10;11(3):e042934. doi: 10.1136/bmjopen-2020-042934.